— Herbalife Nutrition Ltd. (NYSE: HLF) reported its third-quarter 2019 adjusted earnings of $0.73 per share versus $0.64 per share expected.
— Worldwide net sales rose by 0.1% to $1.245 billion versus $1.23 billion expected. Excluding China, net sales increased by 6.1%.
— Sales from the Asia Pacific jumped by 18.3% while that from China fell by 21.7%. North America sales increased by 7.1% while sales from South & Central America declined by 9.1%. EMEA sales rose 2.7% while Mexico sales dropped by 3.9%.
— Volume points of 1.5 billion, increased 2.3% compared to last year. Excluding China, volume points increased by 5.2%.
— Looking ahead into the fourth quarter, the company expects adjusted earnings of $0.52 to $0.72 per share. Net sales growth is predicted to be between a negative of 0.9% and a positive of 4.6%
— For the full year 2019, the company sees adjusted earnings in the range of $2.89 to $3.09 per share. Net sales growth for the full year is projected to be between a negative of 1.2% and a positive of 0.1%.
— For the full year 2020, adjusted earnings are anticipated to be in the range of $2.70 to $3.20 per share. Net sales growth is likely to be in the 1% to 7% range.
— The board of directors announced that John Agwunobi, Co-President, and Chief Health and Nutrition Officer, will become Chief Executive Officer, effective March 30, 2020.
— On March-end, John DeSimone, Co-President and Chief Strategic Officer, will become President. Michael Johnson, who is serving as CEO on an interim basis, will remain Chairman of the board.
Most Popular
Microsoft (MSFT) reports higher revenue and profit for Q3 2024
Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,
GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results
Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales